March Altus Capital Management as of Dec. 31, 2015
Portfolio Holdings for March Altus Capital Management
March Altus Capital Management holds 10 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 15.1 | $1.6M | 8.6k | 190.72 | |
| Incyte Corporation (INCY) | 14.7 | $1.6M | 15k | 108.43 | |
| Regeneron Pharmaceuticals (REGN) | 14.6 | $1.6M | 2.9k | 542.87 | |
| Dex (DXCM) | 14.3 | $1.6M | 19k | 81.91 | |
| Aratana Therapeutics | 11.2 | $1.2M | 219k | 5.58 | |
| ACADIA Pharmaceuticals (ACAD) | 9.8 | $1.1M | 30k | 35.64 | |
| athenahealth | 7.3 | $789k | 4.9k | 161.02 | |
| Eli Lilly & Co. (LLY) | 6.9 | $750k | 8.9k | 84.29 | |
| Aerie Pharmaceuticals | 3.4 | $364k | 15k | 24.33 | |
| Edwards Lifesciences (EW) | 2.8 | $303k | 38k | 7.91 |
